Ira Duarte
Fortune : 681 105 $ au 31/05/2026
Fortune : 681 105 $ au 31/05/2026
Ira Duarte is currently an Independent Director at Terrascend Corp.
since 2022 and EVP, Chief Financial & Accounting Officer at Heron Therapeutics, Inc. starting in 2024.
Former positions include Chief Financial Officer & VP-Controller at Veloxis Pharmaceuticals A from 2018 to 2023, Controller at BioDelivery Sciences International, Inc. from 2014 to 2016, Director-Accounting & Financial Planning at Chiesi USA, Inc. from 2009 to 2013, and Senior Manager at Ernst & Young A. Education includes undergraduate studies at Florida Atlantic University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TERRASCEND CORP. 0,21 % | 30/06/2026 | 657 930 ( 0,21 % ) | 453 972 $ | 31/05/2026 |
HERON THERAPEUTICS INC 0,14 % | 16/06/2026 | 261 073 ( 0,14 % ) | 227 134 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TERRASCEND CORP. | Directeur/Membre du Conseil | 02/12/2022 |
| HERON THERAPEUTICS, INC. | Directeur Financier/CFO | 16/06/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Directeur Financier/CFO | 01/01/2023 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Comptroller/Controller/Auditor | 01/01/2016 |
| CORNERSTONE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2013 |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young A/S
Ernst & Young A/S Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for hospital and specialty care areas including respiratory, rare diseases & critical care | Health Technology |
Terrascend Corp.
Terrascend Corp. Agricultural Commodities/MillingProcess Industries Produces and sells medical cannabis products | Process Industries |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national